Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
CD5-positive B cell subsets in secondary progressive multiple sclerosis.
A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination.
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
The role of complement in neurological and neuropsychiatric diseases.
Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
A Simple Sign for Recognizing Off-Axis OCT Measurement Beam Placement in the Context of Multicentre Studies.
B-cell enrichment and epstein-barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.
Comparison of patient-reported outcome measures in multiple sclerosis.
Methods for the detection of peptidylarginine deiminase activity and protein citrullination.
Multiple sclerosis: Characterization of lesion evolution in relapsing-remitting and secondary progressive multiple sclerosis.
Lack of response to rituximab therapy in patients with neuromyelitis optica: True non-responders or insufficient treatment?
NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.
Disease mechanisms in MS: A role for sodium channels in regulation of macrophage-mediated pathology in multiple sclerosis lesions.
R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment.
Hatha Yoga and Executive Function: A Systematic Review.
Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies.
The role of B cells in the onset of the first demyelinating event of optic neuritis.
Atomic view of a toxic amyloid small oligomer.
Multiple sclerosis, blood flow, and CSF circulation.
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.
Cost-effectiveness analysis of interferon Beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Utility of neuropsychological testing for guiding treatment decisions in paediatric multiple sclerosis.
Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Effects of Glatiramer Acetate in a Spontaneous Model of Autoimmune Neuroinflammation.
Pages
« first
‹ previous
…
266
267
268
269
270
271
272
273
274
…
next ›
last »